Brain, Vol. 112, No. 5, 1231-1260, 1989
© 1989 Guarantors of Brain
research-article |
MYOCLONUS EPILEPSY AND RAGGED-RED FIBRES (MERRF)
1. A CLINICAL, PATHOLOGICAL, BIOCHEMICAL, MAGNETIC RESONANCE SPECTROGRAPHIC AND POSITRON EMISSION TOMOGRAPHIC STUDY
Montreal Neurological Institute and Hospital, and the Department of Neurology and Neurosurgery, McGill University Montreal, Canada
Correspondence to:
Correspondence to: Dr Stirling Carpenter, Montreal Neurological Institute, 3801 University Street, Montréal, Québec, Canada, H3A 2B4
Thirteen patients, including 6 from one family, with the syndrome of myoclonus epilepsy and ragged-red fibres (MERRF) were studied. There was considerable heterogeneity in the age of onset, severity and associated clinical features. Postmortem studies in 3 patients from the one family showed a particular system degeneration. In addition, the youngest and most severely affected family member showed the pathological changes of Leigh's syndrome. Cortical dysfunction is a prominent clinical feature in MERRF, but postmortem examination failed to reveal cortical abnormalities. Positron emission tomographic studies, however, showed decreased cortical metabolic rates for glucose and oxygen utilization, with normal cortical blood flow and cerebral pH. Analyses of kinetic rate constants for uptake and phosphorylation of the glucose analogue, fluorodeoxyglucose showed decreased hexokinase-mediated phosphorylation: normal K1 and k2 values but reduced k3. Phosphorus magnetic resonance spectroscopy studies suggested a normal cerebral intracellular pH. Biochemical studies on muscle homogenates in 6 patients showed partial deficiencies of the activities of certain mitochondrial enzymes in 4 cases, whereas in 2 patients no abnormality was found.
Our data, combined with previous reports, show that MERRF is biochemically and genetically heterogeneous. Our experience, and analysis of the literature, suggests that many cases previously described as the Ramsay Hunt syndrome, as well as other hitherto unclassified system degenerations associated with myoclonus epilepsy, are examples of MERRF. These data permit the formulation of a hypothesis to explain the clinical, biochemical and genetic heterogeneity of MERRF, and its overlap with Leigh's syndrome. We suggest that different biochemical defects of the mitochondrial respiratory chain may cause similar cerebral metabolic effects, as measured by positron emission tomography, resulting in similar phenotypes. Reduced activity of one enzyme, however, may result in different phenotypes, depending on the severity of the defect and its tissue distribution Moreover, the phenotypic expression of certain biochemical defects may be influenced by randomly occurring factors such as fever, which may increase metabolic demand and result in more deleterious cellular metabolic effects.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S.-T. Chen, P.-C. Fan, W.-L. Hwu, and M.-H. Wu Fibrous Dysplasia in a Child with Mitochondrial A8344G Mutation J Child Neurol, December 1, 2008; 23(12): 1447 - 1450. [Abstract] [PDF]
|
|
|
|
 |
|
 F.-G. Lehnhardt, R. Horvath, R. Ullrich, L. Kracht, J. Sobesky, W. Moller-Hartmann, A. H. Jacobs, and W. F. Haupt Altered Cerebral Glucose Metabolism in a Family With Clinical Features Resembling Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome in Association With Multiple Mitochondrial DNA Deletions Arch Neurol, March 1, 2008; 65(3): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fergestad, L. Olson, K. P. Patel, R. Miller, M. J. Palladino, and B. Ganetzky Neuropathology in Drosophila Mutants With Increased Seizure Susceptibility Genetics, February 1, 2008; 178(2): 947 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Heidenreich, T. Klopstock, T. Schirmer, P. Saemann, W. Mueller-Felber, and D. P. Auer Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain. Am. J. Roentgenol., September 1, 2006; 187(3): 820 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zeviani and S. Di Donato Mitochondrial disorders Brain, October 1, 2004; 127(10): 2153 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bosbach, C. Kornblum, R. Schroder, and M. Wagner Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome Brain, May 1, 2003; 126(5): 1231 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Taylor, I. E. Scheffer, and S. F. Berkovic Occipital epilepsies: identification of specific and newly recognized syndromes Brain, April 1, 2003; 126(4): 753 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Knowlton, B. Abou-Khalil, S. M. Sawrie, R. C. Martin, R. E. Faught, and R. I. Kuzniecky In Vivo Hippocampal Metabolic Dysfunction in Human Temporal Lobe Epilepsy Arch Neurol, December 1, 2002; 59(12): 1882 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Clay, M. Behnia, and K. K. Brown Mitochondrial Disease : A Pulmonary and Critical-Care Medicine Perspective Chest, August 1, 2001; 120(2): 634 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Canafoglia, S. Franceschetti, C. Antozzi, F. Carrara, L. Farina, T. Granata, E. Lamantea, M. Savoiardo, G. Uziel, F. Villani, et al. Epileptic phenotypes associated with mitochondrial disorders Neurology, May 22, 2001; 56(10): 1340 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Molnar, A. Valikovics, S. Molnar, L. Tron, P. Dioszeghy, F. Mechler, and B. Gulyas Cerebral blood flow and glucose metabolism in mitochondrial disorders Neurology, August 22, 2000; 55(4): 544 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casali, G. M. Fabrizi, F. M. Santorelli, G. Colazza, M. Villanova, M. T. Dotti, T. Cavallaro, E. Cardaioli, C. Battisti, L. Manneschi, et al. Mitochondrial G8363A mutation presenting as cerebellar ataxia and lipomas in an Italian family Neurology, March 1, 1999; 52(5): 1103 - 1103. [Full Text]
|
|
|
|
 |
|
 P J Lamont, R Surtees, C E Woodward, J V Leonard, N W Wood, and A E Harding Clinical and laboratory findings in referrals for mitochondrial DNA analysis Arch. Dis. Child., July 1, 1998; 79(1): 22 - 27. [Abstract] [Full Text]
|
|
|
|
|
|
R. Cantello, M. Gianelli, C. Civardi, and R. Mutani Focal Subcortical Reflex Myoclonus: A Clinical and Neurophysiological Study Arch Neurol, February 1, 1997; 54(2): 187 - 196. [Abstract] [PDF]
|
|
|
|
|
|
Y. Ohtsuka, R. Amano, E. Oka, and S. Ohtahara Myoclonus Epilepsy With Ragged-Red Fibers: A Clinical and Electrophysiologic Follow-up Study on Two Sibling Cases J Child Neurol, October 1, 1993; 8(4): 366 - 372. [Abstract] [PDF]
|
|
|
|
|
|
W. Fang, C.-C. Huang, C.-C. Lee, S.-Y. Cheng, C.-Y. Pang, and Y.-H. Wei Ophthalmologic Manifestations in MELAS Syndrome Arch Neurol, September 1, 1993; 50(9): 977 - 980. [Abstract] [PDF]
|
|
|
|
|
|
L. D. Kartsounis, D. D. Troung, J. A. Morgan-Hughes, and A. E. Harding The Neuropsychological Features of Mitochondrial Myopathies and Encephalomyopathies Arch Neurol, February 1, 1992; 49(2): 158 - 160. [Abstract] [PDF]
|
|
|
|
|
|
M. G. Harbord, P. A. Hwang, B. H. Robinson, L. E. Becker, A. Hunjan, and E. G. Murphy Infant-Onset Progressive Myoclonus Epilepsy J Child Neurol, April 1, 1991; 6(2): 134 - 142. [Abstract] [PDF]
|
|